WHO vaccine-preventable diseases: monitoring system. 2014 global summary

Last updated 05-Dec-2014 (Data received as of 1-Dec-2014)
Next overall update June 2015
EPI mother and child logo         
Select a country

Development status: Developed economy GNI / capita (US$): 45'2101 Infant (under 12 months) mortality rate: 32
GDP / capita (US$): 40'3381 Child (under 5 years) mortality rate: 42

Population data in thousands3

  2013  2012  2011  2010  2009  2000  1990  1980 
Total population 11'104  11'060  11'007  10'941  10'862  10'268  9'978  9'856 
Births 129  129  128  128  127  114  119  119 
Surviving infants 129  129  128  127  126  114  118  118 
Pop. less than 5 years 655  657  653  643  633  574  594  604 
Pop. less than 15 years 1'886  1'870  1'854  1'836  1'827  1'803  1'801  1'972 
Female 15-49 years 2'481  2'496  2'508  2'517  2'514  2'464  2'445  2'379 

Number of reported case

(Click for retrospective incidence data for Belgium)
Diphtheria
Japanese encephalitis
Measles 39  109  576  40  33 
Mumps 4'573  2'687  15  31  59 
Pertussis 1'142  548  103  133 
Polio*
Rubella
Rubella (CRS)
Tetanus (neonatal)
Tetanus (total)
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Belgium)
Vaccine year result method % card seen                                                
BCG         
DTP1          100  100  99  99  99  97 
DTP3          99  99  98  99  99  95  93 
HepB_BD         
HepB3          98  98  97  97  97  60 
Hib3          92  98  98  98  98  86 
JapEnc         
MCV          92  96  95  95  95  82  85 
MCV2          93  83  83  83 
PCV1          98  98  97  97 
PCV3          93  93  84  84 
Pol3          99  99  98  99  99  96  95 
Rota1          89  89  82  82 
Rota_last          86  86  77  77 
Rubella1          92  96  95  94  94 
TT2plus         
PAB         
VAD1         
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: July 2015

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Belgium)
DTP1 99  99  99  99  99  97  97  98 
DTP3 99  99  98  99  99  95  93  95 
HepB3 98  98  97  97  97  60 
HepB_BD
Hib3 92  98  98  98  98  86 
MCV 92  96  95  95  95  82  85 
MCV2 93  93  83  83  83 
PnC3 93  93 
Pol3 99  99  98  99  99  96  95  99 
Rota_last 86  86 

Number of districts in the country 43  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
 
   
/
|
|
\
Greater or equal to 90% 0
From 80 to 89%
From 50 to 79%
Less than 50%
Proportion of districts
not reporting DTP3 coverage
100
 

Immunization Schedule (2013 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
DTaPHibHepIPV 8, 12, 16 weeks; 15 months; Yes 2, 3, 4, 15 months in Wallonia
DTaPIPV 6 years; Yes 5-6 years in Wallonia
HPV 12 years; +1-2, +6 months; Yes 13-14 years in Wallonia
IPV 8, 16 weeks; 15 months; Yes if hexavalent not possible
Influenza No residents of elderly homes
MMR 12 months; 10 years; Yes 2nd dose at 11-12 years in Wallonia;
MenC_conj 15 months; Yes
Pneumo_conj 8, 16 weeks; 12 months; Yes 2, 4, 12 months in Wallonia
Rotavirus 8, 12, 16 weeks; Yes 3rd dose depend on vaccine presentation
Td No 10 years after Tdap
Tdap 14 years; Yes 15-16 years in Wallonia

Immunizaton indicators

Indicator Expected answer 2013  2012  2011  2010  2009  2008  2007 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2012-2020      2009-2010  2009-2010  2009-2010  depend on region 
Nº of districts with microplans that include activities to raise immunization coverage number              

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  No       

System performance

Total Nº districts in country number 43  43  43  43  43  43  43 
Nº districts with DTP3 coverage >=80% number
% of districts with DTP3 coverage >=80% From 0 to 100%
Nº districts with measles (MCV1) coverage >=95% number              
% of districts with MCV1 coverage >=95% From 0 to 100%              

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  NA  No  No       
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes   

Finance

Estimated percentage of routine vaccines funded by Government From 0 to 100%              

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.